type 2 diabetes

Predictors of prediabetes/type 2 diabetes mellitus identified among U.S. adolescents

by Elana Gotkine edited by Stephanie Baum, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes/type 2 diabetes mellitus (T2DM) among U.S. adolescents, according to a study published online Feb. 25 in PLOS Global Public Health. Eric Peprah Osei, from the […]

Predictors of prediabetes/type 2 diabetes mellitus identified among U.S. adolescents Read More »

Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes

by Angela Yeager, Oregon Health & Science University edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Time to First Composite Heart Failure (HF) Outcome by Treatment and Baseline HF Status and Subtype. Credit: JAMA Internal Medicine (2026). DOI: 10.1001/jamainternmed.2025.7774 An international clinical trial has found that an oral form of semaglutide, a

Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes Read More »

Genetic link between type 2 diabetes and high blood pressure uncovered

by University of Surrey  Editors’ notes  The GIST Add as preferred source Study overview. Credit: Nature Communications (2026). DOI: 10.1038/s41467-025-67449-2 Type 2 diabetes and high blood pressure share a genetic link, according to new research from the University of Surrey, U.K., and the Université de Lille, France. In a large-scale study, scientists examined genetic data linked to type

Genetic link between type 2 diabetes and high blood pressure uncovered Read More »

Big data make hidden genetic drivers of type 2 diabetes visible

by Céline Gravot-Schüppel, Helmholtz Association of German Research Centres edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Statistical power of the causal inference analysis across ancestries. Credit: Nature Metabolism (2026). DOI: 10.1038/s42255-025-01444-1 Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are actually involved

Big data make hidden genetic drivers of type 2 diabetes visible Read More »

New clinical trial demonstrates that eating beef each day does not affect risk factors for type 2 diabetes

by Indiana University edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and

New clinical trial demonstrates that eating beef each day does not affect risk factors for type 2 diabetes Read More »

Routine eye screening provides a window to heart health in type 2 diabetes

by University of Leicester edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Overview of the deep learning workflow utilizing transfer learning for detecting cardiovascular dysfunction from retinal photography. Abbreviations: CAC = coronary artery calcium score; GLS = global longitudinal strain; MPR = myocardial perfusion reserve; LGE = late gadolinium enhancement; LV M/V = left ventricular mass-to-volume ratio. Credit: Scientific Reports (2025). DOI:

Routine eye screening provides a window to heart health in type 2 diabetes Read More »

SGLT2 inhibitors vs GLP-1 receptor agonists for kidney outcomes in individuals with type 2 diabetes

JAMA Internal Medicine Peer-Reviewed Publication JAMA Network About The Study: This comparative effectiveness study found that initiation of sodium-glucose cotransporter-2 inhibitor (SGLT2i) vs glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment in individuals with type 2 diabetes was associated with a lower 5-year risk of chronic kidney disease and a lower 5-year count of acute kidney injury. These

SGLT2 inhibitors vs GLP-1 receptor agonists for kidney outcomes in individuals with type 2 diabetes Read More »

New coffee chemicals show promise for managing type 2 diabetes

by I. Edwards edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Coffee may do more than boost energy. New research suggests that certain compounds found in roasted coffee beans could help slow how quickly sugar enters the bloodstream, a finding that could one day support new foods aimed at

New coffee chemicals show promise for managing type 2 diabetes Read More »

Findings suggest that certain medications for type 2 diabetes reduce risk of dementia

by Keila DePape, McGill University edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Haberdoedas Photography from Pexels A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia. Drawing on clinical data

Findings suggest that certain medications for type 2 diabetes reduce risk of dementia Read More »

Blood metabolite signature offers improved prediction of type 2 diabetes risk

by Mass General Brigham edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: CC0 Public Domain Diabetes, a metabolic disease, is on the rise worldwide, and over 90% of cases are type 2 diabetes, where the body does not effectively respond to insulin. Researchers from Mass General Brigham and Albert

Blood metabolite signature offers improved prediction of type 2 diabetes risk Read More »

Scroll to Top